Market Overview

Boston Scientific Buys Rhythmia Medical; Sees Immaterial in FY13 and FY14

Share:
Related BSX
A Peek Into The Markets: U.S. Stock Futures Mostly Flat; Ford Earnings Miss Views
Boston Scientific Q2 Revenue Beats Guidance, Fueled By Deep Portfolio
Boston Scientific (BSX) Michael F. Mahoney on Q2 2016 Results - Earnings Call Transcript (Seeking Alpha)

Boston Scientific Corporation (NYSE: BSX) has entered into a definitive agreement to acquire privately-held Rhythmia Medical, Inc., a developer of next-generation mapping and navigation solutions for use in cardiac catheter ablations and other electrophysiology procedures, including atrial fibrillation and atrial flutter.  Rhythmia Medical is based in Burlington, MA.  The transaction is expected to close by Friday, October 12^th.

Posted-In: News M&A

 

Related Articles (BSX)

View Comments and Join the Discussion!